Resultados globales: 18 registros encontrados en 0.02 segundos.
Artículos, Encontrados 13 registros
Documentos de investigación, Encontrados 5 registros
Artículos Encontrados 13 registros  1 - 10siguiente  ir al registro:
1.
14 p, 1.3 MB Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools / Besso, María josé (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ; Montivero, Luciana (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ; Lacunza, Ezequiel (Centro de Investigaciones Inmunológicas, Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata) ; Argibay, María cecilia (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ; Abba, Martín (Centro de Investigaciones Inmunológicas, Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata) ; Furlong, Laura Inés (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bello, Ricardo (Departamento de Metodología, Estadística y Matemática, Universidad de Tres de Febrero) ; Vazquez-Levin, Mónica Hebe (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ; Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth most common cancer in women worldwide. Early diagnosis is critical in recurrent EC management. The present study aimed to identify biomarkers of EC early recurrence using a workflow that combined text and data mining databases (DisGeNET, Gene Expression Omnibus), a prioritization algorithm to select a set of putative candidates (ToppGene), protein-protein interaction network analyses (Search Tool for the Retrieval of Interacting Genes, cytoHubba), association analysis of selected genes with clinicopathological parameters, and survival analysis (Kaplan-Meier and Cox proportional hazard ratio analyses) using a The Cancer Genome Atlas cohort. [...]
2020 - 10.3892/or.2020.7648
Oncology Reports, Vol. 44 (june 2020) , p. 873-886  
2.
19 p, 1.5 MB Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model : A development and validation study / Reijnen, Casper (Radboud University Medical Center) ; Gogou, Evangelia (Radboud University) ; Visser, Nicole C. M. (Radboud University Medical Center) ; Engerud, Hilde (Haukeland University Hospital (Bergen, Noruega)) ; Ramjith, Jordache (Radboud University Medical Center) ; van der Putten, Louis J. M. (Radboud University Medical Center) ; van de Vijver, Koen (Universitair Ziekenhuis Gent) ; Santacana, Maria (Hospital Universitari Arnau de Vilanova) ; Bronsert, Peter (University Medical Center, Freiburg, Germany) ; Bulten, Johan (Radboud University Medical Center) ; Hirschfeld, Marc (University Medical Center, Freiburg, Germany) ; Colás Ortega, Eva (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Reques, Armando (Hospital Universitari Vall d'Hebron) ; Mancebo, Gemma (Hospital del Mar (Barcelona, Catalunya)) ; Krakstad, Camilla (Haukeland University Hospital (Bergen, Noruega)) ; Trovik, Jone (Haukeland University Hospital (Bergen, Noruega)) ; Haldorsen, Ingfrid S. (University of Bergen) ; Huvila, Jutta (University of Turku) ; Koskas, Martin (Bichat-Claude Bernard Hospital, Paris) ; Weinberger, Vit (University Hospital in Brno) ; Bednarikova, Marketa (University Hospital Brno) ; Hausnerova, Jitka (University Hospital Brno) ; van der Wurff, Anneke A. M. (Elisabeth-TweeSteden Hospital, Tilburg) ; Matias-Guiu, Xavier (Hospital Universitari Arnau de Vilanova) ; Amant, Frederic (Netherlands Cancer Institute) ; Massuger, Leon F. A. G. (Radboud University Medical Center) ; Snijders, Marc P. L. M. (Canisius-Wilhelmina Hospital) ; Küsters-Vandevelde, Heidi V. N. (Canisius-Wilhelmina Hospital) ; Lucas, Peter J. F. (University of Twente) ; Pijnenborg, Johanna M. A. (Radboud University Medical Center)
Bayesian networks (BNs) are machine-learning-based computational models that visualize causal relationships and provide insight into the processes underlying disease progression, closely resembling clinical decision-making. [...]
2020 - 10.1371/journal.pmed.1003111
PLoS Medicine, Vol. 17 (may 2020)  
3.
14 p, 2.8 MB EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer / Roman-Canal, Berta (Universitat Autònoma de Barcelona) ; Tarragona, Jordi (Institut de Recerca Biomèdica de Lleida) ; Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gatius, Sònia (Institut de Recerca Biomèdica de Lleida) ; Bonnin, Sarah (Centre for Genomic Regulation (CRG), The Barcelona Institute or Science and Technology) ; Ruiz-Miró, Maria (Institut de Recerca Biomèdica de Lleida) ; Sierra, José Enrique (Institut de Recerca Biomèdica) ; Rufas, Maria (Institut de Recerca Biomèdica) ; González, Esperanza (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Porcel, José M. (Arnau de Vilanova University Hospital, IRBLleida. Pleural Medicine Unit) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron) ; Falcón-Pérez, Juan M. (IKERBASQUE, Basque Foundation for Science) ; Ponomarenko, Julia (Universitat Pompeu Fabra) ; Matias-Guiu, Xavier (Institut de Recerca Biomèdica de Lleida) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Colorectal cancer (CRC) is the third leading cause of cancer-related mortality worldwide. Current systematic methods for diagnosing have inherent limitations so development of a minimally-invasive diagnosis, based on the identification of sensitive biomarkers in liquid biopsies could therefore facilitate screening among population at risk. [...]
2019 - 10.1186/s12967-019-1954-8
Journal of translational medicine, Vol. 17 (june 2019)  
4.
0 p, 1.1 MB FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness : Its Relationship With TGF-β1 and NF-κB Pathways / Besso, M.J. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ; Rosso, M. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ; Lapyckyj, L. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ; Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Matos, M.L. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ; Mercogliano, M.F. (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ; Schillaci, R. (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ; Reventós Puigjaner, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron) ; Wernicke, A. (Hospital Italiano de Buenos Aires) ; Orti, R. (Hospital Italiano de Buenos Aires) ; Vazquez-Levin, M.H. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ; Universitat Autònoma de Barcelona
Objective: Endometrial cancer (EC) is the second most common gynecological cancer worldwide. Myometrial invasion (MI) is a key event in EC dissemination. This study aimed to evaluate FXYD5/dysadherin (FXYD5/Dys) expression in EC tissue and uterine aspirate (UA) biopsies and to assess molecular/functional changes associated with its expression in cellular models. [...]
2019 - 10.3389/fonc.2019.01306
Frontiers in Oncology, Vol. 9 (june 2019) , p. 1306  
5.
14 p, 3.0 MB Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer / Herrero, Cristina (Translational Medical Oncology Group (Oncomet). Health Research Institute of Santiago de Compostela (IDIS). University Hospital of Santiago de Compostela (SERGAS)) ; de la Fuente, A. (Nasasbiotech. S.L.) ; Casas-Arozamena, C. (Translational Medical Oncology Group (Oncomet). Health Research Institute of Santiago de Compostela (IDIS). University Hospital of Santiago de Compostela (SERGAS)) ; Sebastian, V. (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Prieto, M. (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Arruebo, M. (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Abalo, A. (Translational Medical Oncology Group (Oncomet). Health Research Institute of Santiago de Compostela (IDIS). University Hospital of Santiago de Compostela (SERGAS)) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moreno-Bueno, G. (Fundacion MD Anderson Internacional) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vilar, A. (Translational Medical Oncology Group (Oncomet). Health Research Institute of Santiago de Compostela (IDIS). University Hospital of Santiago de Compostela (SERGAS)) ; Cueva, J. (Centro de Investigación Biomédica en Red de Cáncer) ; Abal Posada, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ; Muinelo-Romay, L. (Centro de Investigación Biomédica en Red de Cáncer) ; Universitat Autònoma de Barcelona
Tumor-derived extracellular vesicles (EVs) are secreted in large amounts into biological fluids of cancer patients. The analysis of EVs cargoes has been associated with patient's outcome and response to therapy. [...]
2019 - 10.3390/cancers11122000
Cancers, Vol. 11 Núm. 12 (december 2019) , p. 2000  
6.
9 p, 1.7 MB EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer / Roman-Canal, Berta (Hospital Universitari de Bellvitge) ; Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gatius, Sònia (Institut de Recerca Biomèdica de Lleida) ; Bonnin, Sarah (Centre for Genomic Regulation (CRG). The Barcelona Institute or Science and Technology) ; Ruiz-Miró, María (Institut de Recerca Biomèdica de Lleida) ; González, Esperanza (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Ojanguren, Amaia (Department of Thoracic Surgery. Arnau de Vilanova University Hospital. IRBLleida) ; Recuero, José Luis (Department of Thoracic Surgery. Arnau de Vilanova University Hospital. IRBLleida) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron) ; Falcón-Pérez, Juan M (IKERBASQUE. Basque Foundation for Science) ; Ponomarenko, Julia (Centre for Genomic Regulation (CRG). The Barcelona Institute or Science and Technology) ; Porcel, José M. (Pleural Medicine Unit. Arnau de Vilanova University Hospital. IRBLleida) ; Matias-Guiu, Xavier (Hospital Universitari de Bellvitge) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Lung cancer is the leading cause of cancer-related deaths among men and women in the world, accounting for the 25% of cancer mortality. Early diagnosis is an unmet clinical issue. In this work, we focused to develop a novel approach to identify highly sensitive and specific biomarkers by investigating the use of extracellular vesicles (EVs) isolated from the pleural lavage, a proximal fluid in lung cancer patients, as a source of potential biomarkers. [...]
2019 - 10.1038/s41598-019-51578-y
Scientific reports (Nature Publishing Group), Vol. 9 Núm. 1 (january 2019) , p. 15057  
7.
15 p, 1.3 MB Ev-associated miRNAs from peritoneal lavage are a source of biomarkers in endometrial cancer / Roman-Canal, Berta (Universitat Autònoma de Barcelona) ; Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gatius, Sònia (Institut de Recerca Biomèdica de Lleida) ; Bonnin, Sarah (Centre for Genomic Regulation (CRG). The Barcelona Institute or Science and Technology) ; Ruiz-Miró, María (Institut de Recerca Biomèdica de Lleida) ; González, Esperanza (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; González-Tallada, Xavier (Institut de Recerca Biomèdica de Lleida) ; Llordella, Ivanna (Institut de Recerca Biomèdica de Lleida) ; Hernández, Isabel (Institut de Recerca Biomèdica de Lleida) ; Porcel, José M. (Pleural Medicine Unit. Arnau de Vilanova University Hospital. Cancer Biomarker Group. IRBLleida) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron) ; Falcón-Pérez, Juan M. (IKERBASQUE. Basque Foundation for Science) ; Ponomarenko, Julia (Universitat Pompeu Fabra) ; Matias-Guiu, Xavier (Hospital Universitari de Bellvitge) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona. Departament de Medicina
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsible for more than 89,000 deaths every year. Mortality is associated with presence of poor prognostic factors at diagnosis, i. [...]
2019 - 10.3390/cancers11060839
Cancers, Vol. 11 Núm. 6 (2019) , p. 839  
8.
17 p, 4.8 MB ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer / Devis Jauregui, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moiola, Cristian P. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Quiles, Maria Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arbós i Via, Maria Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Stirbat, Tomita Vasilica (Institut Curie) ; Brochard-Wyart, Françoise (Institut Curie) ; García, Ángel (Hospital Universitari Vall d'Hebron) ; Alonso-Alconada, Lorena (Centro de Investigación Biomédica en Red de Cáncer) ; Abal Posada, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ; Díaz-Feijoo, Berta (Hospital Universitari Vall d'Hebron) ; Thomas, William (Department of Natural Sciences, Colby-Sawyer College, New London, New Hampshire, United States of America) ; Dufour, Sylvie (Present address: Université Paris Est, Faculté de Médecine, Créteil, France, INSERM, U955, Equipe 6, Créteil, France) ; Mancebo, Gemma (Hospital del Mar (Barcelona, Catalunya)) ; Alameda, Francesc (Hospital del Mar (Barcelona, Catalunya)) ; Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is one of the most important prognostic factors, being directly associated with tumor recurrence and mortality. [...]
2018 - 10.18632/oncotarget.24625
Oncotarget, Vol. 9 (march 2018) , p. 16648-16664  
9.
9 p, 341.1 KB L1CAM expression in endometrial carcinomas : an ENITEC collaboration study / van der Putten, Louis JM (Department of Obstetrics and Gynaecology, Radboud University Medical Center) ; Visser, Nicole CM (Department of Pathology, Radboud University Medical Center) ; van de Vijver, Koen (Department of Pathology, Anthoni van Leeuwenhoek Hospital) ; Santacana, Maria (Institut de Recerca Biomèdica de Lleida) ; Bronsert, Peter (Institute of Pathology, University Medical Center Freiburg) ; Bulten, Johan (Department of Pathology, Radboud University Medical Center) ; Hirschfeld, Marc (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia, Angel (Hospital Universitari Vall d'Hebron) ; Mancebo, Gemma (Hospital del Mar (Barcelona, Catalunya)) ; Alameda, Francesc (Hospital del Mar (Barcelona, Catalunya)) ; Trovik, Jone (Haukeland University Hospital (Bergen, Noruega)) ; Kopperud, Reidun K (Center for Cancer Biomarkers (CCBIO), University of Bergen) ; Huvila, Jutta (Department of Pathology, University of Turku) ; Schrauwen, Stefanie (Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospital Gasthuisberg) ; Koskas, Martin (Department of Obstetrics and Gynecology, Bichat-Claude Bernard Hospital) ; Walker, Francine (Department of Pathology, Bichat-Claude Bernard Hospital) ; Weinberger, Vit (Department of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University) ; Minar, Lubos (Department of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University) ; Jandakova, Eva (Institute of Pathology, Faculty of Medicine, Masaryk University) ; Snijders, Marc P. L. M (Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital) ; van den Berg-van Erp, Saskia (Department of Pathology, Canisius-Wilhelmina Hospital) ; Matias-Guiu, Xavier (Institut de Recerca Biomèdica de Lleida) ; Salvesen, Helga B (Haukeland University Hospital (Bergen, Noruega)) ; Amant, Frederic (Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospital Gasthuisberg) ; Massuger, Leon FAG (Department of Obstetrics and Gynaecology, Radboud University Medical Center) ; Pijnenborg, Johanna MA (Department of Obstetrics and Gynaecology, TweeSteden Hospital) ; Universitat Autònoma de Barcelona
Identification of aggressive endometrioid endometrial carcinomas (EECs) and non-endometrioid carcinomas (NEECs) is essential to improve outcome. L1 cell adhesion molecule (L1CAM) expression is a strong prognostic marker in stage I EECs, but less is known about L1CAM expression in advanced-stage EECs and NEECs. [...]
2016 - 10.1038/bjc.2016.235
British Journal of Cancer, Vol. 115 (08 2016) , p. 716-724  
10.
14 p, 5.6 MB Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples / Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lesur, Antoine (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Devis Jauregui, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Campos, Alexandre (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ; Cabrera, Silvia (Hospital Universitari Vall d'Hebron) ; van Oostrum, Jan (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Matias-Guiu, Xavier (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Domon, Bruno (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Universitat Autònoma de Barcelona
About 30% of endometrial cancer (EC) patients are diagnosed at an advanced stage of the disease, which is associated with a drastic decrease in the 5-year survival rate. The identification of biomarkers in uterine aspirate samples, which are collected by a minimally invasive procedure, would improve early diagnosis of EC. [...]
2016 - 10.18632/oncotarget.10632
Oncotarget, Vol. 7 (july 2016) , p. 53102-53115  

Artículos : Encontrados 13 registros   1 - 10siguiente  ir al registro:
Documentos de investigación Encontrados 5 registros  
1.
4.2 MB EV-associated miRNAs as a new source of biomarkers in endometrial, colorectal and lung cancers / Roman Canal, Berta ; Matias-Guiu, Xavier, dir. ; Colás Ortega, Eva, dir. ; Llobet Navas, David, dir. ; Comella i Carnicé, Joan Xavier, 1963-, dir. ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
El càncer d'endometri, el càncer colorectal i el càncer de pulmó es troben entre els 10 càncers més freqüents del món. El càncer de pulmó és el càncer més diagnosticat (11. 6% dels casos) i la principal causa de mort per càncer (18. [...]
El cáncer de endometrio, el cáncer colorectal y el cáncer de pulmón se encuentre entre los 10 cánceres más frecuentes del mundo. El cáncer de pulmón es el cáncer más diagnosticado (11. 6% de los casos) y la principal causa de muerte por cáncer (18. [...]
Endometrial cancer (EC), colorectal cancer (CRC) and lung cancer (LC) are on the top-10 list of most common cancers in worldwide. LC is the most commonly diagnosed cancer (11. 6% of the total cases) and the leading cause of cancer death (18. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2020.  
2.
204 p, 18.2 MB Metabolomic study for the identification of diagnostic markers and the characterization of the dissemination process of endometrial cancer / Altadill, Tatiana ; Colás Ortega, Eva, dir. ; Gil Moreno, Antonio, 1965-, dir. ; Cheema, Amrita K, dir. ; Miró, Rosa, dir. ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
El càncer d'endometri (CE) és la malaltia ginecològica més habitual dels països desenvolupats i la quarta causa de càncer en dones. Presenta una incidència que es troba en continu creixement en pacients joves. [...]
Endometrial cancer (EC) is the most common gynaecological malignancy in developed countries and the fourth most common cancer in women. It shows a continuous increasing incidence among younger patients. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2018.  
3.
239 p, 7.1 MB Protein signatures in uterine aspirates to improve diagnosis of endometrial cancer : "the CEMARK project" / Martínez, Elena (Martínez García) ; Reventós i Puigjaner, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Colás Ortega, Eva, dir. ; Gil Moreno, Antonio, 1965-, dir. (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Ponsa Arjona, Immaculada, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
4.
206 p, 5.3 MB Exosomes in uterine aspirates : characterization and identification of diagnostic biomarkers in endometrial cancer / Campoy Moncayo, Irene ; Reventós i Puigjaner, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Colás Ortega, Eva, dir. ; Gil Moreno, Antonio, 1965-, dir. ; Ponsa Arjona, Immaculada, dir. ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
El càncer d'endometri (CE) és la malaltia del tracte genital femení més freqüent als EE. UU i ocupa la quarta posició del rànquing de càncers més comuns en dones. Malauradament, les morts per CE estan augmentant ràpidament i les taxes van incrementar un 2% anual del 2010 al 2014. [...]
Endometrial cancer (EC) is the most common cancer of the female genital tract and the fourth most frequent cancer in women in the United States. Discouraging, EC deaths are increasing rapidly and rates grew about a 2% per year from 2010 to 2014. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
5.
199 p, 5.3 MB The Role of activated leukocyte cell adhesion molecule (ALCAM) in endometrial cancer progression and dissemination / Devis Jauregui, Laura ; Reventós, Jaume, dir. ; Colás Ortega, Eva, dir. ; Gil, Antonio, dir. ; Navarro, Joaquima, dir. ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
[Barcelona] : Universitat Autònoma de Barcelona, 2017  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.